The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Transplantation. 2010 Apr 15;89(7):873-8. doi: 10.1097/TP.0b013e3181ca56e0.
To investigate the impact of cardiac donor participation in high-risk social behaviors (HRSBs) on recipient survival.
Retrospective chart review queried cardiac transplantations performed at our institution from August 1994 to November 2007 involving donors known to have engaged in HRSBs. Kaplan-Meier methodology was used to analyze survival rates, and a Cox proportional hazards regression was performed to determine the impact of donor HRSBs on survival.
We identified 143 donors with social histories containing the following HRSBs: incarceration (n=69), unprofessional tattoos or piercings (n=44), alternative lifestyle practice (n=11), cocaine use (n=60), heroin smoking (n=6), marijuana use (n=79), oral narcotic abuse (n=20), and intravenous drug use (n=21). At the time of donation, viral screens detected 10 donors who were hepatitis B virus (HBV) positive, 11 donors who were hepatitis C virus (HCV) positive, and no donors who were positive for the HIV. One-year and 5-year survival were 92.2% and 84.4%, respectively. Cox regression analysis found only donor HCV infection to be associated with poorer recipient survival (P=0.14).
Using cardiac allografts from high-risk donors who are serologically negative for viruses does not seem to impact recipient survival. There is a considerable risk for transmission of HBV and HCV when these are detected by pretransplant screens. However, if pretransplant screening does not discover donor HBV, HCV, or HIV infection, it is unlikely that subclinical disease transmission will occur.
探讨心脏供体参与高危社会行为(HRSB)对受者生存的影响。
回顾性图表审查查询了 1994 年 8 月至 2007 年 11 月在我们机构进行的心脏移植,涉及已知参与 HRSB 的供体。使用 Kaplan-Meier 方法分析生存率,并进行 Cox 比例风险回归以确定供体 HRSB 对生存的影响。
我们确定了 143 名供体,其社会史包含以下 HRSB:监禁(n=69)、非专业纹身或穿孔(n=44)、替代生活方式实践(n=11)、可卡因使用(n=60)、海洛因吸烟(n=6)、大麻使用(n=79)、口服麻醉品滥用(n=20)和静脉药物使用(n=21)。在捐赠时,病毒筛查发现 10 名供体乙型肝炎病毒(HBV)阳性,11 名供体丙型肝炎病毒(HCV)阳性,没有供体 HIV 阳性。1 年和 5 年生存率分别为 92.2%和 84.4%。Cox 回归分析发现仅供体 HCV 感染与较差的受者生存率相关(P=0.14)。
使用病毒血清学阴性的高危供体心脏同种异体移植物似乎不会影响受者的生存。当通过移植前筛查检测到 HBV 和 HCV 时,存在相当大的传播风险。但是,如果移植前筛查未发现供体 HBV、HCV 或 HIV 感染,则不太可能发生亚临床疾病传播。